These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8609887)

  • 41. Suprasternal gland secretion of male short-tailed opossum induces IP3 generation in the vomeronasal organ.
    Wang D; Chen P; Quan W; Halpern M
    Biochim Biophys Acta; 2007 May; 1770(5):725-32. PubMed ID: 17306463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphoinositide 3-kinase-dependent antagonism in mammalian olfactory receptor neurons.
    Ukhanov K; Brunert D; Corey EA; Ache BW
    J Neurosci; 2011 Jan; 31(1):273-80. PubMed ID: 21209212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and characterization of a G-protein regulatory motif in WAVE1.
    Song KS; Peterson YK; Freidman A; Blumer JB; Sato M; Lanier SM
    FEBS Lett; 2006 Apr; 580(8):1993-8. PubMed ID: 16530190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. G protein antagonists.
    Freissmuth M; Waldhoer M; Bofill-Cardona E; Nanoff C
    Trends Pharmacol Sci; 1999 Jun; 20(6):237-45. PubMed ID: 10366866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of G protein and protein kinase signalling in influenza virus budding in MDCK cells.
    Hui EK; Nayak DP
    J Gen Virol; 2002 Dec; 83(Pt 12):3055-3066. PubMed ID: 12466482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of rat steroid 5 alpha-reductase (isozyme 1) by suramin.
    Taylor MF; Bhattacharyya AK; Collins DC
    Steroids; 1995 Jul; 60(7):452-6. PubMed ID: 7482629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10.
    Paulson CN; John K; Baxley RM; Kurniawan F; Orellana K; Francis R; Sobeck A; Eichman BF; Chazin WJ; Aihara H; Georg GI; Hawkinson JE; Bielinsky AK
    Open Biol; 2019 Aug; 9(8):190117. PubMed ID: 31409229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.
    Mancini F; Toro CM; Mabilia M; Giannangeli M; Pinza M; Milanese C
    Biochem Pharmacol; 1999 Sep; 58(5):851-9. PubMed ID: 10449196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Gαi-GIV binding interface is a druggable protein-protein interaction.
    DiGiacomo V; de Opakua AI; Papakonstantinou MP; Nguyen LT; Merino N; Blanco-Canosa JB; Blanco FJ; Garcia-Marcos M
    Sci Rep; 2017 Aug; 7(1):8575. PubMed ID: 28819150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G protein coupling of receptors to ionic channels and other effector systems.
    Birnbaumer L; Yatani A; VanDongen AM; Graf R; Codina J; Okabe K; Mattera R; Brown AM
    Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):13S-22S. PubMed ID: 1702677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.
    Berg A; Berg T
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3349-3352. PubMed ID: 28624143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QEHA27, a peptide that binds to G-protein beta gamma-subunits, reduces the inhibitory effect of 5-HT on the Ca2+ current of rat dorsal raphe neurons.
    Chen Y; Penington NJ
    Neurosci Lett; 1997 Mar; 224(2):87-90. PubMed ID: 9086463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suramin and the suramin analogue NF307 discriminate among calmodulin-binding sites.
    Klinger M; Bofill-Cardona E; Mayer B; Nanoff C; Freissmuth M; Hohenegger M
    Biochem J; 2001 May; 355(Pt 3):827-33. PubMed ID: 11311147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of suramin on the activities of degradative enzymes of sphingolipids in rats.
    Constantopoulos G; Rees S; Cragg BG; Barranger JA; Brady RO
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):87-97. PubMed ID: 7291729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for the Recognition of Non-Nucleotide Antagonists Within the Transmembrane Domains of the Human P2Y(1) Receptor.
    Guo D; von Kügelgen I; Moro S; Kim YC; Jacobson KA
    Drug Dev Res; 2002 Dec; 57(4):173-181. PubMed ID: 23105165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients.
    Dhar S; Gullbo J; Csoka K; Eriksson E; Nilsson K; Nickel P; Larsson R; Nygren P
    Eur J Cancer; 2000 Apr; 36(6):803-9. PubMed ID: 10762755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. G proteins as drug targets.
    Höller C; Freissmuth M; Nanoff C
    Cell Mol Life Sci; 1999 Feb; 55(2):257-70. PubMed ID: 10188585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha.
    Alzani R; Cozzi E; Corti A; Temponi M; Trizio D; Gigli M; Rizzo V
    Biochemistry; 1995 May; 34(19):6344-50. PubMed ID: 7756262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drugs interacting with G protein alpha subunits: selectivity and perspectives.
    Chahdi A; Daeffler L; Gies JP; Landry Y
    Fundam Clin Pharmacol; 1998; 12(2):121-32. PubMed ID: 9565765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of suramin on the biological activity of the two isoforms of the rat 5 alpha-reductase.
    Poletti A; Rabuffetti M; Martini L
    Steroids; 1996 Aug; 61(8):504-5. PubMed ID: 8870171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.